Researchers identify specific protein that helps breast cancer to spread

Researchers identify specific protein that helps breast cancer to spread
Dr Aihoa Mielgo from the Department of Cancer Studies at the Institute of Translational Medicine. Credit: University of Liverpool

Researchers from the University's Institute of Translational Medicine have found an explanation for how breast cancer spreads to the lungs, which could potentially hold the key to preventing the progression of the disease.

Breast remains the leading cause of cancer death in women due to metastasis (the spread of a cancer from one organ or part of the body to another) and the development of resistance to established therapies.

Macrophages are the most abundant immune cells in the and can both inhibit and support cancer progression.

Insulin-like growth factors

The research team, led by Dr. Ainhoa Mielgo, conducted a study to gain a better understanding of how associated macrophages support with the aim of developing more effective therapies against this disease.

They found that these macrophages express high levels of specific proteins called 'insulin-like growth factors' (IGFs) 1 and 2 and this helps cells grow in the lungs.

IGF-1 and 2 are hormones found naturally in your blood. Their main job is to regulate the effects of growth hormone (GH) in your body. However, as shown in this study, tumours can also express these proteins to help them grow and metastasize to other organs.

Significant reduction in metastasis

75% of examined showed activation of IGF receptors which correlates with increased macrophage infiltration and tumour progression.

In patients with , activation of IGF receptors increased to 87%.

The researchers found there was a significant reduction in tumour cell growth and lung metastasis in pre-clinical breast cancer models when IGFs were blocked in combination with paclitaxel, a chemotherapeutic agent commonly used to treat some of the most aggressive types of breast cancer.

The results of this research study have been published in Oncogene.

Improving treatments

Dr. Mielgo said: "Our findings provide the rationale for further developing the combination of paclitaxel with IGF blockers for the treatment of invasive breast cancer.

"A better understanding of the mechanisms underlying the metastatic spreading of breast cancer is critical to improve treatment and patient outcome."

Lucy Ireland, Ph.D. student in Dr. Mielgo's group and first author of this publication, said: "I am thrilled by our findings, as the combination therapy is more effective than the current treatment in pre-clinical models of breast cancer."


Explore further

Potential therapy identified for aggressive breast cancer

More information: Lucy Ireland et al. Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer, Oncogene (2018). DOI: 10.1038/s41388-017-0115-x
Journal information: Oncogene

Citation: Researchers identify specific protein that helps breast cancer to spread (2018, January 25) retrieved 24 June 2019 from https://medicalxpress.com/news/2018-01-specific-protein-breast-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
14 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more